Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page


My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2001 1
2002 15
2003 12
2004 27
2005 28
2006 33
2007 37
2008 51
2009 69
2010 72
2011 121
2012 143
2013 172
2014 216
2015 260
2016 278
2017 302
2018 320
2019 397
2020 444
2021 532
2022 640
2023 583
2024 292

Text availability

Article attribute

Article type

Publication date

Search Results

4,470 results

Results by year

Filters applied: . Clear all
Page 1
Expanding PROTACtable genome universe of E3 ligases.
Liu Y, Yang J, Wang T, Luo M, Chen Y, Chen C, Ronai Z, Zhou Y, Ruppin E, Han L. Liu Y, et al. Nat Commun. 2023 Oct 16;14(1):6509. doi: 10.1038/s41467-023-42233-2. Nat Commun. 2023. PMID: 37845222 Free PMC article.
Targeting neoadjuvant chemotherapy-induced metabolic reprogramming in pancreatic cancer promotes anti-tumor immunity and chemo-response.
Tang R, Xu J, Wang W, Meng Q, Shao C, Zhang Y, Lei Y, Zhang Z, Liu Y, Du Q, Sun X, Wu D, Liang C, Hua J, Zhang B, Yu X, Shi S; Chinese Study Group for Pancreatic Cancer. Tang R, et al. Among authors: liu y. Cell Rep Med. 2023 Oct 17;4(10):101234. doi: 10.1016/j.xcrm.2023.101234. Cell Rep Med. 2023. PMID: 37852179 Free PMC article.
Characterization of intratumor microbiome in cancer immunotherapy.
Zhang Z, Gao Q, Ren X, Luo M, Liu Y, Liu P, Liu Y, Ye Y, Chen X, Liu H, Han L. Zhang Z, et al. Among authors: liu y. Innovation (Camb). 2023 Jul 12;4(5):100482. doi: 10.1016/j.xinn.2023.100482. eCollection 2023 Sep 11. Innovation (Camb). 2023. PMID: 37560331 Free PMC article. Review. No abstract available.
Combining single-cell sequencing and spatial transcriptome sequencing to identify exosome-related features of glioblastoma and constructing a prognostic model to identify BARD1 as a potential therapeutic target for GBM patients.
Zhao S, Wang Q, Ni K, Zhang P, Liu Y, Xie J, Ji W, Cheng C, Zhou Q. Zhao S, et al. Among authors: liu y. Front Immunol. 2023 Aug 31;14:1263329. doi: 10.3389/fimmu.2023.1263329. eCollection 2023. Front Immunol. 2023. PMID: 37727789 Free PMC article.
New techniques: a roadmap for the development of HCC immunotherapy.
Jiang D, Ma X, Zhang X, Cheng B, Wang R, Liu Y, Zhang X. Jiang D, et al. Among authors: liu y. Front Immunol. 2023 Jun 22;14:1121162. doi: 10.3389/fimmu.2023.1121162. eCollection 2023. Front Immunol. 2023. PMID: 37426674 Free PMC article. Review.
The role of TRPV1 in RA pathogenesis: worthy of attention.
Qu Y, Fu Y, Liu Y, Liu C, Xu B, Zhang Q, Jiang P. Qu Y, et al. Among authors: liu y. Front Immunol. 2023 Sep 8;14:1232013. doi: 10.3389/fimmu.2023.1232013. eCollection 2023. Front Immunol. 2023. PMID: 37744324 Free PMC article. Review.
4,470 results